https://www.selleckchem.com/products/rrx-001.html
7% (95% CI 19-45.1)). Overall, the endovascular treated patients faced more than 50% increased risk of major amputation or death compared to that of a vein bypass, after adjusting for co-morbidity and TASC-classification (HR 1.56 (95% CI 1.21-2.05)). As expected, postoperative complications, length of hospital stay (LOS) and reinterventions were more frequent in the bypass groups. CONCLUSION In this non-randomized study, autologous vein bypass was superior to both PTA/S and synthetic bypass in regard to amputation free survival and over
Gefällt mir
Kommentar
Teilen
